Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.

Ahmed A, Fonarow GC, Zhang Y, Sanders PW, Allman RM, Arnett DK, Feller MA, Love TE, Aban IB, Levesque R, Ekundayo OJ, Dell'Italia LJ, Bakris GL, Rich MW.

Am J Med. 2012 Apr;125(4):399-410. doi: 10.1016/j.amjmed.2011.10.013. Epub 2012 Feb 7.

2.

Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.

Ahmed A, Rich MW, Zile M, Sanders PW, Patel K, Zhang Y, Aban IB, Love TE, Fonarow GC, Aronow WS, Allman RM.

Am J Med. 2013 Feb;126(2):150-61. doi: 10.1016/j.amjmed.2012.06.031.

3.

Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.

Bowling CB, Sanders PW, Allman RM, Rogers WJ, Patel K, Aban IB, Rich MW, Pitt B, White M, Bakris GC, Fonarow GC, Ahmed A.

Int J Cardiol. 2013 Jul 15;167(1):151-6. doi: 10.1016/j.ijcard.2011.12.056. Epub 2012 Jan 17.

4.

A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.

Zhang Y, Fonarow GC, Sanders PW, Farahmand F, Allman RM, Aban IB, Love TE, Levesque R, Kilgore ML, Ahmed A.

Am J Cardiol. 2011 Nov 15;108(10):1443-8. doi: 10.1016/j.amjcard.2011.06.066. Epub 2011 Sep 3.

5.

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

Mujib M, Patel K, Fonarow GC, Kitzman DW, Zhang Y, Aban IB, Ekundayo OJ, Love TE, Kilgore ML, Allman RM, Gheorghiade M, Ahmed A.

Am J Med. 2013 May;126(5):401-10. doi: 10.1016/j.amjmed.2013.01.004. Epub 2013 Mar 16.

6.

Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.

Edner M, Benson L, Dahlström U, Lund LH.

Eur Heart J. 2015 Sep 7;36(34):2318-26. doi: 10.1093/eurheartj/ehv268. Epub 2015 Jun 11.

PMID:
26069212
7.

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.

Lund LH, Benson L, Dahlström U, Edner M.

JAMA. 2012 Nov 28;308(20):2108-17. doi: 10.1001/jama.2012.14785.

PMID:
23188027
8.

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.

9.

Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.

Patel K, Fonarow GC, Kitzman DW, Aban IB, Love TE, Allman RM, Gheorghiade M, Ahmed A.

Eur J Heart Fail. 2012 Oct;14(10):1179-88. Epub 2012 Jul 3.

10.

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.

Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C.

Eur J Heart Fail. 2013 Nov;15(11):1236-44. doi: 10.1093/eurjhf/hft089. Epub 2013 Jun 19.

11.

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A.

Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.

PMID:
25554369
12.

Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.

Wohlfahrt P, Melenovsky V, Kotrc M, Benes J, Jabor A, Franekova J, Lemaire S, Kautzner J, Jarolim P.

JACC Heart Fail. 2015 Oct;3(10):829-39. doi: 10.1016/j.jchf.2015.05.012.

PMID:
26450001
13.

Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.

Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.

JAMA Intern Med. 2014 Mar;174(3):347-54. doi: 10.1001/jamainternmed.2013.12700.

PMID:
24343093
14.

Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan.

Tang CH, Chen TH, Wang CC, Hong CY, Huang KC, Sue YM.

Eur J Heart Fail. 2013 Oct;15(10):1194-202. doi: 10.1093/eurjhf/hft082. Epub 2013 May 12.

15.

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.

Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H.

Am J Kidney Dis. 2016 May;67(5):728-41. doi: 10.1053/j.ajkd.2015.10.011. Epub 2015 Nov 18.

PMID:
26597926
16.

Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.

Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.

Am J Cardiol. 2008 Nov 15;102(10):1356-60. doi: 10.1016/j.amjcard.2008.07.014. Epub 2008 Sep 12.

PMID:
18993155
17.

Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.

Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A.

Int J Cardiol. 2012 Jan 26;154(2):128-33. doi: 10.1016/j.ijcard.2010.09.006. Epub 2010 Oct 14.

18.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.

PMID:
17540211
20.

Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.

Savarese G, Edner M, Dahlström U, Perrone-Filardi P, Hage C, Cosentino F, Lund LH.

Int J Cardiol. 2015 Nov 15;199:415-23. doi: 10.1016/j.ijcard.2015.07.051. Epub 2015 Jul 21.

PMID:
26247798

Supplemental Content

Support Center